Araştırma Makalesi
BibTex RIS Kaynak Göster

Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer

Yıl 2019, Cilt: 23 Sayı: 2, 298 - 303, 27.06.2025

Öz

Diabetic foot ulcer usually develops due to lack of knowledge and awareness regarding the consequences of the disease progression and poor foot care among diabetics. The objective of the study is to enhance knowledge, attitude and clinical practice among diabetic foot ulcer patients through pharmacist counseling, and to assist physician in the selection of cost effective antibiotics. Data on the disease condition such as duration of illness, type of diabetes, category of infections, classification of foot ulcer, risk factors, comorbidities and antibiotics used were collected and analyzed. Additionally, the details of culture sensitivity report for sensitive and resistant microorganisms with respect to antibiotics were recorded. Appropriate patient education on diabetic foot ulcer helps to improve their knowledge, attitude, and practice significantly. The commonest microbial isolates identified in diabetic foot ulcer patients were Klebsiella pneumonia, Pseudomonas aeruginosa and Staphylococcus aureus. Culture sensitive drugs found were meropenem, amoxicillin with clavulanic acid, clindamycin and the resistant drugs were cefepime, levofloxacin and penicillin.

Kaynakça

  • [1] Tentolouris N, Boulton AJM, Al-Sabbagh S, Jude EB, Walker MG. Mortality in diabetic & non- diabetic patients after amputations performed from 1990-1995-5 year follow up study. Diabetes Care. 2004; 27(7): 1598-1604. [CrossRef]
  • [2] Desalu OO, Salawu FK, Jimoh AK, Adekoya AO. Diabetic foot care: Self-reported knowledge and practice among patients attending three tertiary hospitals in Nigeria. Ghana Med J. 2011; 45(2): 60-65. [CrossRef] [3] Kafaie P, Noorbala MT, Soheilikhah S, Rashidi M. Evaluation of patients' education on foot self-care status in diabetic patients. Iran Red Crescent Med J. 2012; 14(12) 829–832. [CrossRef]
  • [4] Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29(6) 1288-1293. [CrossRef]
  • [5] Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovska A, Mauricio D, Piaggesi A, Reike H, Spraul M, Van Acker K, Van Baal S, Van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia. 2008; 51(10): 1826-1834. [CrossRef]
Yıl 2019, Cilt: 23 Sayı: 2, 298 - 303, 27.06.2025

Öz

Kaynakça

  • [1] Tentolouris N, Boulton AJM, Al-Sabbagh S, Jude EB, Walker MG. Mortality in diabetic & non- diabetic patients after amputations performed from 1990-1995-5 year follow up study. Diabetes Care. 2004; 27(7): 1598-1604. [CrossRef]
  • [2] Desalu OO, Salawu FK, Jimoh AK, Adekoya AO. Diabetic foot care: Self-reported knowledge and practice among patients attending three tertiary hospitals in Nigeria. Ghana Med J. 2011; 45(2): 60-65. [CrossRef] [3] Kafaie P, Noorbala MT, Soheilikhah S, Rashidi M. Evaluation of patients' education on foot self-care status in diabetic patients. Iran Red Crescent Med J. 2012; 14(12) 829–832. [CrossRef]
  • [4] Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29(6) 1288-1293. [CrossRef]
  • [5] Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovska A, Mauricio D, Piaggesi A, Reike H, Spraul M, Van Acker K, Van Baal S, Van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia. 2008; 51(10): 1826-1834. [CrossRef]
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Farmakoloji ve Terapötikler, Temel Farmakoloji
Bölüm Articles
Yazarlar

Smithamol Sunny

Swathy Pradeep

Anita Ann Sunny

Rama Parthasarathy

Shanmugasundaram Rajeshkumar

Sankar Veintramuthu

Yayımlanma Tarihi 27 Haziran 2025
Yayımlandığı Sayı Yıl 2019 Cilt: 23 Sayı: 2

Kaynak Göster

APA Sunny, S., Pradeep, S., Ann Sunny, A., Parthasarathy, R., vd. (2025). Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer. Journal of Research in Pharmacy, 23(2), 298-303.
AMA Sunny S, Pradeep S, Ann Sunny A, Parthasarathy R, Rajeshkumar S, Veintramuthu S. Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer. J. Res. Pharm. Haziran 2025;23(2):298-303.
Chicago Sunny, Smithamol, Swathy Pradeep, Anita Ann Sunny, Rama Parthasarathy, Shanmugasundaram Rajeshkumar, ve Sankar Veintramuthu. “Patient Counseling, Risk Factors and Comorbidity Assessment in Diabetic Foot Ulcer”. Journal of Research in Pharmacy 23, sy. 2 (Haziran 2025): 298-303.
EndNote Sunny S, Pradeep S, Ann Sunny A, Parthasarathy R, Rajeshkumar S, Veintramuthu S (01 Haziran 2025) Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer. Journal of Research in Pharmacy 23 2 298–303.
IEEE S. Sunny, S. Pradeep, A. Ann Sunny, R. Parthasarathy, S. Rajeshkumar, ve S. Veintramuthu, “Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer”, J. Res. Pharm., c. 23, sy. 2, ss. 298–303, 2025.
ISNAD Sunny, Smithamol vd. “Patient Counseling, Risk Factors and Comorbidity Assessment in Diabetic Foot Ulcer”. Journal of Research in Pharmacy 23/2 (Haziran 2025), 298-303.
JAMA Sunny S, Pradeep S, Ann Sunny A, Parthasarathy R, Rajeshkumar S, Veintramuthu S. Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer. J. Res. Pharm. 2025;23:298–303.
MLA Sunny, Smithamol vd. “Patient Counseling, Risk Factors and Comorbidity Assessment in Diabetic Foot Ulcer”. Journal of Research in Pharmacy, c. 23, sy. 2, 2025, ss. 298-03.
Vancouver Sunny S, Pradeep S, Ann Sunny A, Parthasarathy R, Rajeshkumar S, Veintramuthu S. Patient counseling, risk factors and comorbidity assessment in diabetic foot ulcer. J. Res. Pharm. 2025;23(2):298-303.